For the Inventor, By the Inventor

Enter assignee name

Miami, FL, United States of America

Coulter Corporation

USPTO Granted Patents = 99

Trademarks = 6

Forward Citations = 3,048

Loading Chart...

Loading Chart...

104 inventors (with patents filed for the assignee):

Olavi Siiman (14 out of 24 patents)

Thomas R Russell (14 out of 19 patents)

Kenneth H Kortright (13 out of 15 patents)

4. Wallace H Coulter (10 out of 32 patents)

5. Alexander Burshteyn (9 out of 17 patents)

6. Carlos M Rodriguez (9 out of 20 patents)

7. Ravinder K Gupta (9 out of 16 patents)

8. Timothy J Fischer (8 out of 40 patents)

9. John A Maples (7 out of 15 patents)

10. Ronald D Paul (7 out of 9 patents)

11. Carole Jo Young (7 out of 18 patents)

12. David E Hofheinz (7 out of 7 patents)

13. John D Hollinger (6 out of 8 patents)

14. James H Carter (6 out of 7 patents)

15. Frank J Lucas (5 out of 12 patents)

Core Competencies:

Hematological Composition

Leukocyte Determination

Monoclonal Antibody

Flow Cytometry

Control Cells

Enzyme Activity

Reticulocyte Analysis

Particle Sizing

DNA Removal

Biodegradable Coatings

Cell Screening

Assay Reagents

99 patents: Sort by Forward Citations

1. 6362003 - Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof (2002-03-26),

2. 6281335 - Hybridoma and anti-KC-4 humanized monoclonal antibody (2001-08-28),

3. 6159740 - Method and apparatus for screening obscured or partially obscured cells (2000-12-12),

4. 5871946 - Method for determining activity of enzymes in metabolically active whole (1999-02-16),

5. 5861311 - Preserved, non-infectious control cells prepared by the modulation or (1999-01-19),

6. 5849513 - Assay reagent (1998-12-15),

7. 5834315 - Cyanide-free reagent and method for hemoglobin determination and (1998-11-10),

8. 5798217 - Method of analyzing tumor cell DNA content through tumor cell enrichment (1998-08-25),

9. 5786224 - Reagent and method for differential determination of leukocytes in blood (1998-07-28),

10. 5783673 - Method of preferential labelling of a phycobiliprotein with an (1998-07-21),

11. 5776720 - Assay reagent (1998-07-07),

12. 5776706 - Polymeric particles having a biodegradable gelatin or aminodextran (1998-07-07),

13. 5763204 - Preparation of preserved, non-infectious control cell for use in the (1998-06-09),

14. 5733719 - Method of making an assay compound (1998-03-31),

15. 5707877 - Biodegradable gelatin-aminodextran particle coatings of and processes (1998-01-13),

Company Overview

Coulter Corporation, based in Miami, FL, specializes in hematology diagnostics, focusing on the development and manufacturing of advanced diagnostic instruments and reagents. The company is recognized for its expertise in hematological composition analysis, leukocyte determination, and reticulocyte analysis, utilizing core technologies such as flow cytometry and monoclonal antibodies. Coulter's innovations support clinical laboratories in delivering accurate and efficient blood analysis, enhancing patient care through reliable diagnostic solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

99 Patents

#8 in Miami, FL

#87 in Florida

#3,828 in US

#7,857 in the World

Miami, FL, United States of America

Coulter Corporation

Forward Citations = 3,048

104 inventors:

Olavi Siiman (14 out of 24 patents)

Thomas R Russell (14 out of 19 patents)

Kenneth H Kortright (13 out of 15 patents)

4. Wallace H Coulter (10 out of 32 patents)

5. Alexander Burshteyn (9 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Coulter Corporation. Retrieved from https://idiyas.com/company/coulter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…